Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/17/2007

Net product sales increased 28% over third quarter 2006 to $177 million

SAN DIEGO, Oct. 17 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended September 30, 2007. The Company reported total revenue of $190.0 million for the third quarter, including net product sales of $177.4 million. Net loss for the quarter ended September 30, 2007 was $39.8 million, or $0.30 per share. At September 30, 2007, the Company held cash, cash equivalents and short-term investments of approximately $1.1 billion.

"BYETTA and SYMLIN, our first-in-class diabetes medicines, have been on the market for nearly 30 months and continued to show growth in physician adoption, prescriptions and reported revenue in the third quarter," said Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals. "Additionally we continued to advance our pipeline drug candidates and remain on track to report key clinical data later this quarter from our once-weekly exenatide long-acting release program and our integrated neurohormone obesity program."

Quarter ended September 30, 2007

Net product sales of $177.4 million for the third quarter include $161.1 million for BYETTA(R) (exenatide) injection and $16.3 million for SYMLIN(R) (pramlintide acetate) injection. This compares to net product sales of $138.8 million, consisting of $126.4 million for BYETTA and $12.4 million for SYMLIN for the same period in 2006.

Revenues under collaborative agreements were $12.6 million for the quarter ended September 30, 2007, compared to $8.2 million for the same period in 2006. The increase reflects higher cost-sharing payments from Lilly to equalize develo
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...ISBANE, Calif., July 24 /- ...hat it will release second quarter 2008,financial ... July 31, 2008,at 4:00 p.m. Eastern time. A live c...Mune at 4:30 p.m. Eastern time that same day., To... (U.S.) or,706-634-0154 (international), conferenc...
(Date:7/24/2008)... Healthcare Technology Veteran to Help Spearhe...alth Monitoring Systems (HMS), (http://www.hmsinc....said today,that Karen S. Dockrell has been appoint...han 17 years of experience in sales, sales,managem...care technology,medical device and pharmaceutical...
(Date:7/24/2008)...DFORD, Mass., July 24 /- Ho...uccessful completion of the tender,offer by its di...for all,outstanding shares of Third Wave Technolog...r share in cash., The subsequent offering period ...Wednesday, July 23, 2008. The initial tender offer...
(Date:7/24/2008)...sue Dissection System Represents Important Advance... Technologies -, PALO ALTO, Calif., July 24 /PRNe...ompany that has developed a new tissue dissection ...nounced that the U.S. Food and,Drug Administration...t its,PEAK(R) Surgery System for use in general su...
Breaking Biology Technology:InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31 2Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4
... I recently participated in a roundtable discussio...ts were managers responsible for talent management... firms. The subject of discussion was agile resour...kforce more flexible. The goal of agile resourcing...have the right people, with the right skills, in t...
... Apple provides cluster computers to biology prof...SON A team of University of Wisconsin-Madison sta...uster for Bioinformatics awards . , ,Professor Mi...unduz Keles, Christina Kendziorski and Bret Larget... biological data. , ,Some of the fields they work ...
... MADISON Back in his math teacher days, Al Jacobs...lking about lily pads. Imagine a colony of lily pa...y: How long would it take for an area of two squar...are feet? , ,Only 17 days, thanks to the power of ... 32 and so on, until on the 17th day, 131,072 squa...
... What one thing, if done extremely well, is a powe...ogy commercialization organizations? And what, if ...e answer is delegation. How well you delegate will...ble to commercialize your technology. In this arti...ximize your technology commercialization marketing...
Other Biology Technology:Stuck in Talent Gridlock 2Stuck in Talent Gridlock 3Doubling the lily pads: Controlling the explosion in health care costs 2Doubling the lily pads: Controlling the explosion in health care costs 3Fire up your marketing by delegating 2
(Date:7/25/2008)...born with hydrocephalus, or "water on the brain" m...from the brain to reduce harmful pressure. , Wh...fection in children is very high for a variety of ...another surgery to replace the shunt, bringing wit...ological complications and an increased risk of de...
(Date:7/24/2008)...led by Massachusetts General Hospital (MGH) invest...mic research and medicine a robust method for gen...ar DNA sequences for inactivation or repair. In ...hers describe an efficient, publicly available met...ZFNs), which can be used to induce specific genomi...
(Date:7/24/2008)...by researchers from Columbia University,s Mailman ...challenging issues in infant health and preventing...s. In these settings, HIV-infected mothers had be...ants, they should exclusively breast-feed, followe...h. But according to the study conducted in Lusaka,...
(Date:7/24/2008)... researchers have found a molecular link between c...sm. The discovery reveals new possibilities for th... diseases. , Paolo Sassone-Corsi, Distinguished ...agues have identified that an essential protein ca...thms, works in balance with another protein called...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2New efficiency record for solar cells 5414 1New efficiency record for solar cells 5414 2Food 4 Less Expands Discounted Generic Drug Program 19403 1Food 4 Less Expands Discounted Generic Drug Program 19403 2Food 4 Less Expands Discounted Generic Drug Program 19403 3STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 1STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 2STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 3STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 4STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 5Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 19397 1Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 19397 2
...o speed development of new medical products throug...ug Administration (FDA) today issued a final guida...harmacogenomics allows health care providers to id...response and predict the best possible treatment o...sts are helping to identify cancers that have a go...
...rly detection of other tumors one day may be as si...cording to recent studies by UCLA researchers. , ...d here at the 96th Annual Meeting of the American ...ts reported that genetic "biomarkers" isolated in ...bout nine out of 10 cases. , A recent study by thi...
...sha National Park in northern Namibia, and ecologi...on for elephants. "It,s so fantastic here," she sa...bras, ostriches--it,s the Garden of Eden." , A re... of Medicine, O,Connell-Rodwell has come to one of... the mysterious and complex world of elephant comm...
...y,s Pratt School of Engineering have created a new...e. Inserted inside the esophagus, the probe create...s for current ultrasound technology to image a sin...derable potential not only for evaluating the cond...erapeutic treatment devices, the researchers said....
Other Biology News:FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 2FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 3Biomarkers isolated from saliva successfully predict oral and breast cancer 2Scientists journey to southern Africa to unravel the secret world of elephant communication 2Scientists journey to southern Africa to unravel the secret world of elephant communication 3Scientists journey to southern Africa to unravel the secret world of elephant communication 4Scientists journey to southern Africa to unravel the secret world of elephant communication 5Scientists journey to southern Africa to unravel the secret world of elephant communication 6Scientists journey to southern Africa to unravel the secret world of elephant communication 7Scientists journey to southern Africa to unravel the secret world of elephant communication 8Scientists journey to southern Africa to unravel the secret world of elephant communication 9Scientists journey to southern Africa to unravel the secret world of elephant communication 10Scientists journey to southern Africa to unravel the secret world of elephant communication 11Scientists journey to southern Africa to unravel the secret world of elephant communication 12Duke engineers develop new 3-D cardiac imaging probe 2
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity.
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles
Immunogen: Human Respiratory Syncytial Virus (RSV) and Bovine Respiratory Syncytial Virus (BRSV) Fusion protein Storage: -20 C, Avoid Freeze/Thaw Cycles
IHC detection kit for PCNA in cells and tissues
Biology Products: